Dark Forest Capital Management LP Biomarin Pharmaceutical Inc Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $774,817 - $860,523	9,108 Added 110.0%	17,388 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $684,858 - $792,470	7,901 Added 2084.7%	8,280 $717,000
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $33,253 - $44,445	379 New	379 $36,000
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $58,169 - $68,633	708 New	708 $60,000
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $6,454 - $8,232	-90 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $6,729 - $7,692	90 New	90 $7,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.